Endoplasmic reticulum stress inhibition reduces hypertension through the preservation of resistance blood vessel structure and function

Journal of Hypertension

Volumn 34, Issue 8, 2016, Pages 1556-1569

  Carlisle, Rachel E ^a   Werner, Kaitlyn E ^a   Yum, Victoria ^a   Lu, Chao ^a   Tat, Victor ^a   Memon, Muzammil ^a   No, Yejin ^a   Ask, Kjetil ^a   Dickhout, Jeffrey G ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

4 phenylbutyric acid; endoplasmic reticulum stress; essential hypertension; nitric oxide; superoxide

Indexed keywords

4 PHENYLBUTYRIC ACID; HYDROETHIDINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TUNICAMYCIN; 4-PHENYLBUTYRIC ACID; ARYLBUTYRIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CATHETERIZATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ESSENTIAL HYPERTENSION; FLUORESCENCE MICROSCOPY; HEART MUSCLE CONTRACTILITY; HUMAN; MESENTERIC ARTERY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; REAL TIME POLYMERASE CHAIN REACTION; RESISTANCE BLOOD VESSEL; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT OUTCOME; VASCULAR SMOOTH MUSCLE CELL; VASODILATATION; WESTERN BLOTTING; WISTAR KYOTO RAT; ANIMAL; BLOOD PRESSURE; DRUG EFFECTS; HYPERTENSION; MALE; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOOD PRESSURE; ENDOPLASMIC RETICULUM STRESS; HYPERTENSION; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; PHENYLBUTYRATES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; TUNICAMYCIN; VASCULAR RESISTANCE; VASODILATION;

EID: 84966750060     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000943     Document Type: Article

References (52)

1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-19.
2. Inrig JK. Antihypertensive agents in hemodialysis patients: a current perspective. Semin Dial 2010; 23:290-297.
3. de Cavanagh EM, Ferder L, Carrasquedo F, Scrivo D, Wassermann A, Fraga CG, et al. Higher levels of antioxidant defenses in enalapriltreated versus nonenalapril-Treated hemodialysis patients. Am J Kidney Dis 1999; 34:445-455.
4. Passauer J, Pistrosch F, Bussemaker E. Nitric oxide in chronic renal failure. Kidney Int 2005; 67:1665-1667.
5. Baylis C Nitric Oxide Deficiency in Chronic Kidney Disease.Am J Physiol Renal Physiol 2008; 294:F1-F9
6. Giles TD, Sander GE, Nossaman BD, Kadowitz PJ. Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins. J Clin Hypertens (Greenwich) 2012; 14:198-205.
7. Rajapakse NW, Mattson DL. Role of cellular L-Arginine uptake and nitric oxide production on renal blood flow and arterial pressure regulation. Curr Opin Nephrol Hypertens 2013; 22:45-50.
8. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996; 93:13176-13181.
9. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 1999; 33:937-942.
10. Quyyumi AA, Patel RS Endothelial Dysfunction and Hypertension: Cause or Effect? Hypertension 2010; 55:1092-1094
11. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009; 53:323-330.
12. Hultstrom M. Development of structural kidney damage in spontaneously hypertensive rats. J Hypertens 2012; 30:1087-1091.
13. Bennett MA, Hillier C, Thurston H. Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long-Term treatment with perindopril, quinapril, hydralazine or amlodipine. J Hypertens 1996; 14:389-397.
14. Spitler KM, Matsumoto T, Webb RC. Suppression of endoplasmic reticulum stress improves endothelium-dependent contractile responses in aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2013; 305:H344-H353.
15. Dickhout JG, Colgan SM, Lhotak S, Austin RC. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome-A balancing act between plaque stability and rupture. Circulation 2007; 116:1214-1216.
16. Dickhout JG, Hossain GS, Pozza LM, Zhou J, Lhotak S, Austin RC. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol 2005; 25:2623-2629.
17. Hong HJ, Hsiao G, Cheng TH, Yen MH. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 2001; 38:1044-1048.
18. Dickhout JG, Krepinsky JC. Endoplasmic reticulum stress and renal disease. Antioxid Redox Signal 2009; 11:2341-2352.
19. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2012; 334:1081-1086.
20. Dickhout JG, Carlisle RE, Austin RC. Inter-relationship between cardiac hypertrophy, heart failure and chronic kidney disease-endoplasmic reticulum stress as a mediator of pathogenesis. Circ Res 2011; 108:629-642.
21. Malhotra JD, Kaufman RJ Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or A Double-edged Sword? Antioxid Redox Signal 2007 9 2277-2277.
22. Carlisle RE, Brimble E, Werner KE, Cruz GL, Ask K, Ingram AJ, et al. 4-Phenylbutyrate inhibits tunicamycin-induced acute kidney injury via CHOP/GADD153 repression. PLoS One 2014; 9:e84663.
23. Basseri S, Lhotak S, Sharma AM, Austin RC. The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lipid Res 2009; 50:2486-2501.
24. Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L, DiPetrillo K. Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens 2008; 21:1288-1291.
25. Dickhout JG, Lee R. Structural and functional analysis of small arteries from young spontaneously hypertensive rats. Hypertension 1997; 29:781-789.
26. Parasuraman S, Raveendran R. Measurement of invasive blood pressure in rats. J Pharmacol Pharmacother 2012; 3:172-177.
27. Dickhout JG, Carlisle RE, Jerome DE, Mohammed-Ali Z, Jiang H, Yang G, et al. Integrated stress response modulates cellular redox state via induction of cystathionine gamma-lyase: cross-Talk between integrated stress response and thiol metabolism. J Biol Chem 2012; 287:7603-7614.
28. Cao SS, Zimmermann EM, Chuang BM, Song B, Nwokoye A, Wilkinson JE, et al. The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice. Gastroenterology 2013; 144:989.e6-1000.e6.
29. Hall KL, Harding JW, Hosick HL. Isolation and characterization of clonal vascular smooth muscle cell lines from spontaneously hypertensive and normotensive rat aortas. In Vitro Cell Dev Biol 1991; 27A:791-798.
30. Hossain GS, Lynn EG, Maclean KN, Zhou J, Dickhout JG, Lhotak S, et al. Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression. J Am Heart Assoc 2013; 2:e000134.
31. Steireif C, Garcia-Prieto CF, Ruiz-Hurtado G, Pulido-Olmo H, Aranguez I, Gil-Ortega M, et al. Dissecting the genetic predisposition to albuminuria and endothelial dysfunction in a genetic rat model. J Hypertens 2013; 31:2203-2212; discussion 12.
32. Dornas WC, Silva ME. Animal models for the study of arterial hypertension. J Biosci 2011; 36:731-737.
33. Dickhout JG, Lee RM. Increased medial smooth muscle cell length is responsible for vascular hypertrophy in young hypertensive rats. Am J Physiol Heart Circ Physiol 2000; 279:H2085-H2094.
34. Kassan M, Galan M, Partyka M, Saifudeen Z, Henrion D, Trebak M, et al. Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice. Arterioscler Thromb Vasc Biol 2012; 32:1652-1661.
35. Tang C, Koulajian K, Schuiki I, Zhang L, Desai T, Ivovic A, et al. Glucose-induced beta cell dysfunction in vivo in rats: link between oxidative stress and endoplasmic reticulum stress. Diabetologia 2012; 55:1366-1379.
36. Raffai G, Durand MJ, Lombard JH. Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats. Am J Physiol Heart Circ Physiol 2011; 301:H1341-H1352.
37. Young CN, Cao X, Guruju MR, Pierce JP, Morgan DA, Wang G, et al. ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension. J Clin Invest 2012; 122:3960-3964.
38. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membranepermeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998; 32:59-64.
39. Chen X, Patel K, Connors SG, Mendonca M, Welch WJ, Wilcox CS. Acute antihypertensive action of Tempol in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2007; 293:H3246-H3253.
40. Laight DW, Andrews TJ, Haj-Yehia AI, Carrier MJ, Anggard EE. Microassay of superoxide anion scavenging activity in vitro. Environ Toxicol Pharmacol 1997; 3:65-68.
41. Krishna MC, Russo A, Mitchell JB, Goldstein S, Dafni H, Samuni A Do Nitroxide Antioxidants Act As Scavengers of O2-. or As SOD Mimics? J Biol Chem 1996; 271:26026-26031
42. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 1990; 29:2802-2807.
43. Xu H, Fink GD, Galligan JJ. Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2-in DOCA-salt rats. Hypertension 2004; 43:329-334.
44. Mori Y, Ohyanagi M, Koida S, Ueda A, Ishiko K, Iwasaki T. Effects of endothelium-derived hyperpolarizing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneously hypertensive rats. Hypertens Res 2006; 29:187-195.
45. Bussemaker E, Popp R, Fisslthaler B, Larson CM, Fleming I, Busse R, et al. Aged spontaneously hypertensive rats exhibit a selective loss of EDHF-mediated relaxation in the renal artery. Hypertension 2003; 42:562-568.
46. Mantelli L, Amerini S, Ledda F. Roles of nitric oxide and endotheliumderived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol 1995; 25:595-602.
47. Fujii K, Tominaga M, Ohmori S, Kobayashi K, Koga T, Takata Y, et al. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res 1992; 70:660-669.
48. Kang KT, Sullivan JC, Sasser JM, Imig JD, Pollock JS. Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats. Hypertension 2007; 49:893-901.
49. Carlisle RE, Heffernan A, Brimble E, Liu L, Jerome D, Collins CA, et al. TDAG51 mediates epithelial-To-mesenchymal transition in human proximal tubular epithelium. Am J Physiol Renal Physiol 2012; 303:F467-F481.
50. Lichter-Konecki U, Diaz GA, Merritt JL 2nd, Feigenbaum A, Jomphe C, Marier JF, et al. Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate. Mol Genet Metab 2011; 103:323-329.
51. Ding L, Chapman A, Boyd R, Wang HD. ERK activation contributes to regulation of spontaneous contractile tone via superoxide anion in isolated rat aorta of angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 2007; 292:H2997-H3005.
52. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999; 100:2267-2275.